Every 10-Q that TRANSUITE ORG INC (TRSO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow TRSO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TRSO filings page.
Transuite.Org Inc. reports that it has transformed into a technology-focused holding company centered on intelligent new‑energy infrastructure, e‑bike charging, Web3 and digital asset platforms. For the six months ended June 30, 2026, revenue rose to $248,036 from $50,000 a year earlier, driven mainly by e‑bike charging revenue of $246,882 and initial online medical education revenue of $1,154.
The company remains deeply unprofitable, with a net loss of $8,001,684 and a stockholders’ deficit of $309,843. A substantial portion of expenses is non‑cash: stock‑based compensation totaled $7,634,463 for the period. Cash and cash equivalents increased to $106,993, supported by a $130,000 convertible note, a $95,038 loan, and a $10 million equity purchase facility with Williamsburg under which no funds have been drawn. New convertible debt created derivative liabilities of $586,191, contributing to a loss on change in fair value of $474,191.
Management discloses an accumulated deficit of $45,587,093 and explicitly states that the company’s ability to continue as a going concern depends on achieving profitable operations and obtaining additional financing. Plans include revenue growth in e‑bike charging, integration of acquired entities, further platform development and continued use of equity and debt financing.
Transuite.Org Inc. reported a larger Q1 2026 loss as it pivots into Web3, digital asset and infrastructure platforms. Revenue reached $121,784, up from zero a year earlier, mainly from e-bike charging and online medical education services. The company posted a net loss of $3,253,813, driven largely by $3,317,607 of non-cash stock-based compensation linked to strategic services and prior grants.
Total assets were $496,370, with cash of $4,545 and positive working capital of $108,897 after reducing stock payable. Stockholders’ equity improved to $109,931 from a prior deficit, helped by share issuances for debt settlement, acquisitions and services. However, the accumulated deficit rose to $40,815,538 and management again raised substantial doubt about the company’s ability to continue as a going concern, stating it will rely on additional debt and equity financing and an equity purchase agreement of up to $10 million with Williamsburg Venture Holdings to fund operations.
Transuite.Org Inc. (TRSO) reported its first AI consulting revenue but very large losses as it executes an aggressive transformation strategy. For the nine months ended September 30, 2025, the company generated $115,000 of revenue and recorded a net loss of $27,965,403, driven mainly by $27,938,890 of stock-based compensation paid in shares to consultants.
Shares outstanding jumped from 4,046,760 at December 31, 2024 to 47,869,093 at September 30, 2025 as TRSO issued stock for services, debt conversion, and acquisitions. It acquired 51% of SolanAI Global Ltd. and 100% of Xirangsheng (Shenzhen) Health Technology Co., Ltd., booking $12,501,149 of goodwill and $24,607,847 of intangible assets and a $22,875,281 contingent liability tied to XRS valuation.
Working capital improved from a $194,191 deficit to positive $146,800, but cash was only $14,030. Management disclosed substantial doubt about continuing as a going concern and plans to rely on related-party loans and up to $10,000,000 of potential equity financing under its Williamsburg agreement while integrating recent acquisitions and pursuing additional AI deals.